Ellen AB Logo

Ellen AB

Develops research-based probiotic and prebiotic products for women's intimate health and pH balance.

ELN | ST

Overview

Corporate Details

ISIN(s):
SE0014730347
LEI:
549300KJGSYJ46ZTZ557
Country:
Sweden
Address:
Barnhusgatan 4 ög nv, 111 23 Stockholm
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ellen AB is a biotechnology and Fem-Tech company, founded in 2000, that specializes in women's intimate health. The company develops and markets a range of innovative and natural products designed to maintain a healthy pH balance for women throughout all stages of life, including menstruation, pregnancy, and menopause. Ellen's offerings are grounded in scientific research and its portfolio includes products such as probiotic tampons, which contain the patented strain of lactic acid bacteria Lacto Naturel (LN), as well as prebiotic cleansers, probiotic creams, and vaginal pH tests. The company's mission is to provide effective, research-based solutions that contribute to women's well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ellen AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Ellen AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Ellen AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Idorsia Ltd Logo
Develops and commercializes small-molecule medicines for CNS, cardiovascular, and immune disorders.
Switzerland
IDIA
ILDONG HOLDINGS CO.,LTD  Logo
South Korea
000230
IL DONG PHARMACEUTICAL CO., LTD. Logo
Develops & manufactures pharmaceuticals, APIs, and offers CMO services for various diseases.
South Korea
249420
ILSUNG IS CO., LTD. Logo
Develops pharmaceuticals like antibiotics and anesthetics, expanding into CNS and GI therapies.
South Korea
003120
ILYANG PHARMACEUTICAL CO.,LTD Logo
Develops & manufactures drugs, vaccines & supplements for oncology & gastroenterology needs.
South Korea
007570
I-Mab Logo
A clinical-stage biopharma developing immuno-oncology agents and bispecific antibodies for cancer.
United States of America
IMAB
ImageneBio, Inc. Logo
A clinical-stage biopharma pioneering therapies for immune & inflammatory diseases.
United States of America
IMA
IMGT Corporation Limited Logo
Develops a drug delivery platform using ultrasound and nanotech for oncology.
South Korea
456570
Immatics N.V. Logo
Develops T-cell redirecting immunotherapies (ACT & TCR Bispecifics) for solid tumor cancers.
United States of America
IMTX
Immix Biopharma, Inc. Logo
Developing safer cell therapies for AL Amyloidosis and hematologic malignancies.
United States of America
IMMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.